Beranda › Asma › Massachusetts
Uji klinis Asma di Massachusetts
15 studi untuk Asma mencari peserta di lokasi di Massachusetts.
Kota di Massachusetts
Teks studi resmi (Bahasa Inggris)
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Worcester
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06932263ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, Boston
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07301255A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Brigham and Women's Hospital, Boston
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07219173A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- Research Site 20, Fall River
Menerima pesertaFase 3
Usia 12 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07359846A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Research Site, Boston
- Research Site, Boston
Menerima pesertaFase 3
Usia 5 hingga 11 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06023589A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12119, Boston
- Teva Investigational Site 12182, South Dartmouth
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT06664619A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Boston
Menerima pesertaFase 2
Usia 4 hingga 11 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07525375Registry of Asthma Characterization and Recruitment 3 (RACR3)
- Boston Children's Hospital: Department of Immunology, Boston
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT05272241Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Boston
Menerima pesertaFase 3
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT06307665A Study of CDX-622 in Participants With Mild to Moderate Asthma
- Brigham and Women's Hospital, Boston
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT07330778Protocol CAUSE-03 / CHEETAH
- Boston University School of Medicine: Pulmonary Center, Boston
- Boston Children's Hospital: Department of Immunology, Boston
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 1 Jul 2026 · NCT06136091Asthma Link Effectiveness Trial
- University of Massachusetts Chan Medical School, Worcester
Menerima peserta
Usia 5 hingga 14 · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT06388460Home Hospital for Suddenly Ill Adults
- Brigham and Women's Hospital, Boston
- Brigham and Women's Faulkner Hospital, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT03524222Individualizing Treatment for Asthma in Primary Care (Full Study)
- Reliant Medical Group, Worcester
Menerima pesertaFase 4
Usia 13 hingga 75 · Semua jenis kelamin · Diperbarui 29 Okt 2025 · NCT07052942Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
- Massachusetts General Hospital, Boston
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 25 Sep 2025 · NCT00595491Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.